Clinical Trials Directory

Trials / Completed

CompletedNCT01022281

Early Diagnosis in Glaucoma With GDxVcc

Evaluation of Scanning Laser Polarimetry Findings in Individuals With Exfoliation Syndrome Compared With Normal Controls

Status
Completed
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Accepted

Summary

To compare the Retina Nerve Fiber Layer thickness, measured with Scanning Laser Polarimetry in subjects with exfoliation syndrome and normal controls and to evaluate the value of scanning laser polarimetry in the early diagnosis and management of exfoliative glaucoma

Detailed description

To compare the Scanning Laser Polarimetry findings in subjects with exfoliation syndrome and normal controls and to evaluate the value of scanning laser polarimetry in the early diagnosis and management of exfoliative glaucoma. Prospective study in progress. The investigators compare and analyze the scanning laser polarimetry parameters in consecutive subjects with exfoliation syndrome and normal intraocular pressure and compared them with consecutive normal controls. Randomly selected patients with exfoliation syndrome and normal controls undergo a comprehensive ophthalmic exam which includes 3 IOP measurements, corneal pachymetry, automated perimetry and assessment of the retina nerve fiber layer with scanning laser polarimetry. The investigators hypothesize that patients with exfoliation syndrome may show worse scanning laser polarimetry parameters than normal controls and this may prove to be an early sign of exfoliative glaucoma development. Evaluation of retina nerve fiber layer thickness may help us in identifying earlier those individuals with exfoliation syndrome that will develop exfoliative glaucoma.

Conditions

Timeline

Start date
2007-09-01
Primary completion
2010-12-01
Completion
2012-12-01
First posted
2009-12-01
Last updated
2014-05-12

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01022281. Inclusion in this directory is not an endorsement.